These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7433062)

  • 1. [Treatment of rheumatoid arthritis by means of purified placental human IGG. 1st clinical and immunological results].
    Sany J; Andary M; Clot J; Bonneau M
    Nouv Presse Med; 1980 Oct; 9(36):2660-2. PubMed ID: 7433062
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of rheumatoid polyarthritis with IgG eluted from the placenta. Results of an open study on 31 patients].
    Sany J; Combe B; Clot J; Andary A; Cosso B
    Rev Rhum Mal Osteoartic; 1986; 53(7-9):473-9. PubMed ID: 3787154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulating effect of human placenta-eluted gamma globulins in rheumatoid arthritis.
    Sany J; Clot J; Bonneau M; Andary M
    Arthritis Rheum; 1982 Jan; 25(1):17-24. PubMed ID: 7066033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-immunological comparisons during levamisole treatment of rheumatoid arthritis - abuse of correlations between cellular immunity indicators and treatment results].
    Chumakova MM; Bunchuk NV
    Ter Arkh; 1981; 53(6):83-7. PubMed ID: 6974413
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis.
    van Laar JM; Miltenburg AM; Verdonk MJ; Leow A; Elferink BG; Daha MR; Cohen IR; de Vries RR; Breedveld FC
    J Autoimmun; 1993 Apr; 6(2):159-67. PubMed ID: 8098938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid arthritis; encouraging clinical results in its treatment with placental extract.
    DILLON RN; MAJNARICH JJ
    Med Times; 1954 Mar; 82(3):199-205. PubMed ID: 13153586
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune function in patients with rheumatoid arthritis treated with etanercept.
    Moreland LW; Bucy RP; Weinblatt ME; Mohler KM; Spencer-Green GT; Chatham WW
    Clin Immunol; 2002 Apr; 103(1):13-21. PubMed ID: 11987981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new treatment for rheumatoid arthritis].
    Vervaeren J
    J Pharm Belg; 2002; 57(4):82-8. PubMed ID: 12357696
    [No Abstract]   [Full Text] [Related]  

  • 9. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
    Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD
    Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyl radical damaged immunoglobulin G in patients with rheumatoid arthritis: biochemical and immunological studies.
    Rasheed Z
    Clin Biochem; 2008 Jun; 41(9):663-9. PubMed ID: 18359293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between the rheumatoid rosette test and the clinical picture of rheumatoid arthritis (author's transl)].
    Domljan Z; Horvat Z
    Lijec Vjesn; 1981 Jun; 103(6):245-7. PubMed ID: 6976498
    [No Abstract]   [Full Text] [Related]  

  • 12. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do etanercept-naive patients with rheumatoid arthritis respond better to infliximab than patients for whom etanercept has failed?
    Yazici Y; Erkan D
    Ann Rheum Dis; 2004 May; 63(5):607-8; author reply 608. PubMed ID: 15082503
    [No Abstract]   [Full Text] [Related]  

  • 14. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
    Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
    J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of tumour necrosis factor {alpha} significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis.
    Yazdani-Biuki B; Stadlmaier E; Mulabecirovic A; Brezinschek R; Tilz G; Demel U; Mueller T; Brickmann K; Graninger WB; Brezinschek HP
    Ann Rheum Dis; 2005 Aug; 64(8):1224-6. PubMed ID: 16014683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-TNF-alpha-treatment of arthritis--4-year follow-up].
    Petri A; Dreyer L; Danneskiold-Samsøe B; Terslev L; Bliddal H
    Ugeskr Laeger; 2003 Nov; 165(48):4649-52. PubMed ID: 14677465
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of placental serum in the treatment of rheumatoid arthritis.
    TUFTS M
    Wis Med J; 1954 Dec; 53(12):615-6; passim. PubMed ID: 13217374
    [No Abstract]   [Full Text] [Related]  

  • 19. [High-dose immunoglobulin therapy of rheumatoid arthritis].
    Horneff G; Schwab J; Holtz N; Kalden JR; Burmester GR
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():110-5; discussion 116-7. PubMed ID: 8499738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies.
    Jonsdottir T; Forslid J; van Vollenhoven A; Harju A; Brannemark S; Klareskog L; van Vollenhoven RF
    Ann Rheum Dis; 2004 Sep; 63(9):1075-8. PubMed ID: 15066863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.